A detailed history of Nbc Securities, Inc. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Nbc Securities, Inc. holds 532 shares of DNLI stock, worth $14,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
532
Previous 532 -0.0%
Holding current value
$14,614
Previous $12,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$14.96 - $23.22 $2,947 - $4,574
197 Added 58.81%
532 $12,000
Q3 2023

Nov 03, 2023

BUY
$20.63 - $30.17 $6,911 - $10,106
335 New
335 $6,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.69B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.